Beckman Daniella (CIK 1513422) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-04). Recent activity: Buy TNGX (44,330 shares), Sell TNGX (10,204 shares), Sell TNGX (113 shares), Sell BPMC (3,902 shares), Sell BPMC (10,842 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | Buy | 44,330 | $0 |
| 2026-02-04 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | Sell | 10,204 | $125,101 |
| 2026-02-04 | Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | Sell | 113 | $1,458 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Director | Sell | 3,902 | $0 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Director | Sell | 10,842 | $0 |
| 2025-06-24 | Blueprint Medicines Corp (BPMC) | Director | Buy | 3,902 | $499,924 |
来源：SEC Form 4 申报文件 · 截至 2026-02-04